Beta-blocker therapy of severe congestive heart failure in infants with left to right shunts

Area of Science:

• Pediatric Cardiology
• Pharmacology
• Cardiovascular Physiology

Background:

• Infants with large left-to-right shunts often develop severe congestive heart failure.
• Conventional therapy with digoxin and diuretics may not fully address the neurohumoral imbalances in these patients.

Purpose of the Study:

• To evaluate the clinical and neurohumoral effects of adding low-dose propranolol to conventional therapy in infants with severe congestive heart failure.
• To assess the impact on heart failure scores and the renin-angiotensin-aldosterone system.

Main Methods:

• A study involving 6 infants with severe congestive heart failure due to large left-to-right shunts.
• Addition of low-dose propranolol to existing digoxin and diuretic treatment.
• Monitoring of clinical heart failure scores and neurohumoral markers, including the renin-angiotensin-aldosterone system.

Main Results:

• A significant decrease in heart failure scores was observed in the infants.
• A marked reduction of approximately 70% in the activity of the highly activated renin-angiotensin-aldosterone system was noted.
• The combination therapy demonstrated a beneficial clinical and neurohumoral response.

Conclusions:

• Low-dose propranolol, when added to conventional therapy, offers a beneficial approach for managing severe congestive heart failure in infants with large left-to-right shunts.
• This therapeutic strategy effectively improves clinical outcomes and modulates the neurohumoral system, specifically the renin-angiotensin-aldosterone pathway.